Observe Medical ASA: Mandatory notification of trade by primary insider
Observe Medical ASA (OBSRV) · publisert 22. oktober 2025 kl. 15:27 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Jørgen Mann | CEO | Kjøp | 30 000 | 0,679 NOK | 22. oktober 2025 | NO0013457952 | XOSL |
Vedlegg
- OMASA_PDMR_appendix_JM2210.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, 22 October 2025: Observe Medical ASA (the "Company") has been informed
that Jørgen Mann, CEO and primary insider in the Company, has today purchased
30,000 shares in the Company as further specified in the attached notification
form.
Following the purchase, Jørgen Mann holds 870,000 shares in the Company.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.